Resistance Training With Blood Flow Restriction in Hemophilia

NCT ID: NCT05568524

Last Updated: 2026-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-15

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objectives of this study are to evaluate safety and chronic effects of a low-load resistance exercise intervention (elbow flexions and extensions, and knee extensions) with blood flow restriction in people with hemophilia on quality of life, pain, and on physical and neuromuscular function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemophilia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

The training program for the control group consists of a telerehabilitation with traditional moderate-to-high load (60%-80% 1RM) exercises (the same as the intervention group sans BFR), utilizing elastic bands. This program for the control group will be conducted in an in-home real-time audio and video style and supervised by a physiotherapist.

Group Type ACTIVE_COMPARATOR

Control

Intervention Type OTHER

Moderate-to-high load (60%-80% 1RM) resistance exercise

BFRT

The BFR training program for the intervention group consists of elbow flexion and extension, and knee extension exercises performed with low load (elastic bands; equivalent to 30% 1RM) and concurrent BFR (upper limb 50% AOP; lower limb 60% AOP). Subjects will perform 4 sets (30, 15, 15 and 15 reps) of each exercise with 30 s rest between sets and 5-minute rest between exercises.

Group Type EXPERIMENTAL

BFRT

Intervention Type OTHER

Low-load (30% 1RM) resistance exercise with blood flow restriction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BFRT

Low-load (30% 1RM) resistance exercise with blood flow restriction

Intervention Type OTHER

Control

Moderate-to-high load (60%-80% 1RM) resistance exercise

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of hemophilia A or B and undergoing prophylaxis;
* willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations;
* approval by their hematologist to participate in the exercise program;
* age between 18 and 60 years;
* informed consent signed.

Exclusion Criteria

* the inability to attend exercise sessions at least twice a week for 8 consecutive weeks;
* non adherence to instruction on proper exercise technique;
* surgical procedures performed 6 weeks prior to or during the exercise program; - participation in any other form of exercise, not previously done, during the study;
* changes in medication during the study;
* a major bleeding episode that posed a risk or prevented exercise;
* another hemostatic defect;
* need for major surgery;
* withdrawal of informed consent.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Valencia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sofia Perez-Alenda

Dean of Faculty of Physiotherapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sofía Pérez Alenda

Role: PRINCIPAL_INVESTIGATOR

University of Valencia

Joaquín Calatayud

Role: STUDY_CHAIR

University of Valencia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Facultat de Fisioteràpia

Valencia, Valencia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hemo-BFR-22-24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.